http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008505160-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 |
| filingDate | 2005-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2008505160-A |
| titleOfInvention | Solid form of magnesium salt of (S) -omeprazole and method for producing the same |
| abstract | a) Crystallizing S-omeprazole magnesium salt from a solution of S-omeprazole magnesium salt in a solvent system containing a methanol / water mixture with an amount of water of 0.01 ml or more per gram of S-omeprazole magnesium salt starting material B) separating the S-omeprazole magnesium salt appearing in the previous step; c) separating the free organic solvent from the obtained S-omeprazole magnesium salt, or separating both the free solvent and the solvating solvent; A new solid form of the active ingredient magnesium salt of S-omeprazole obtainable by a production process comprising: This new solid form is obtained by a reliable method with high yield and high optical purity that is useful for the production of pharmaceuticals containing the active ingredient. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010540413-A |
| priorityDate | 2004-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.